Patents matching “targeted”

US 11896672

Targeted nucleic acid conjugate compositions

ARBUTUS BIOPHARMA CORPORATION · Granted Feb 13, 2024 · Expires Feb 8, 2044

US 11851671

Programmable assembly of virus composites for receptor-targeted gene delivery

Regents of the University of Minnesota · Granted Dec 26, 2023 · Expires Dec 21, 2043

US 11814624

Targeted non-viral DNA insertions

The Regents of the University of California · Granted Nov 14, 2023 · Expires Nov 9, 2043

US 11806432

Compositions, methods and uses for thermally stable multi-targeted antigens

The Regents of the University of Colorado, a Body Corporate · Granted Nov 7, 2023 · Expires Nov 2, 2043

US 11787778

Bi-functional compounds and methods for targeted ubiquitination of androgen receptor

Montelino Therapeutics Inc. · Granted Oct 17, 2023 · Expires Oct 12, 2043

US 11786479

Nucleic acid nanocapsules for drug delivery and targeted gene knockdown

UNIVERSITY OF CONNECTICUT · Granted Oct 17, 2023 · Expires Oct 12, 2043

US 11780931

CD47 targeted therapies for the treatment of infectious disease

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 10, 2023 · Expires Oct 5, 2043

US 11766403

Peptide-targeted liposomal delivery for treatment, diagnosis, and imaging of diseases and disorders

United States Government as represented by the Department of Veterans Affairs · Granted Sep 26, 2023 · Expires Sep 21, 2043

US 11723922

CXCR6-transduced T cells for targeted tumor therapy

Ludwig-Maximilians-Universitat Munchen · Granted Aug 15, 2023 · Expires Aug 10, 2043

US 11691972

Compounds for targeted degradation of BRD9

C4 THERAPEUTICS, INC. · Granted Jul 4, 2023 · Expires Jun 29, 2043

US 11684638

Targeted delivery system, system components, and methods

Regents of the University of Minnesota · Granted Jun 27, 2023 · Expires Jun 22, 2043

US 11666661

Methods and compounds for targeted autophagy

The Regents of the University of California · Granted Jun 6, 2023 · Expires Jun 1, 2043

US 11661441

Cell-reactive, long-acting, or targeted compstatin analogs and uses thereof

Apellis Pharmaceuticals, Inc. · Granted May 30, 2023 · Expires May 25, 2043

US 11649468

Targeted integration into the PPP1R12C locus

Sangamo Therapeutics, Inc. · Granted May 16, 2023 · Expires May 11, 2043

US 11642319

Targeted nanogels for urinary bladder therapies

The Regents of the University of Colorado · Granted May 9, 2023 · Expires May 4, 2043

US 11596694

Compositions and methods for predicting response to NaPi2b-targeted therapy

Mersana Therapeutics, Inc. · Granted Mar 7, 2023 · Expires Mar 2, 2043

US 11590171

Targeted replacement of endogenous T cell receptors

The Regents of the University of California · Granted Feb 28, 2023 · Expires Feb 23, 2043

US 11566253

Targeted gene demethylation in plants

The Regents of the University of California · Granted Jan 31, 2023 · Expires Jan 26, 2043

US 11547759

Bi-functional compounds and methods for targeted ubiquitination of androgen receptor

Montelino Therapeutics Inc. · Granted Jan 10, 2023 · Expires Jan 5, 2043

US 11534495

Tissue factor-targeted antibody-drug conjugate

SHANGHAI MIRACOGEN INC. · Granted Dec 27, 2022 · Expires Dec 22, 2042

US 11512110

Targeted delivery system and methods of use therefor

SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted Nov 29, 2022 · Expires Nov 24, 2042

US 11512287

Targeted disruption of T cell and/or HLA receptors

Sangamo Therapeutics, Inc. · Granted Nov 29, 2022 · Expires Nov 24, 2042

US 11504394

Targeted ionophore-based metal delivery

The Regents of the University of California · Granted Nov 22, 2022 · Expires Nov 17, 2042

US 11491145

Combination therapies comprising targeted therapeutics

Madrigal Pharmaceuticals, Inc. · Granted Nov 8, 2022 · Expires Nov 3, 2042